Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 30.24 M25.11 M — Research & development 502 K— — Operating income 24.14 M24.04 M — Non-Operating Income, Total 1.48 M8.46 M — Interest expense, net of interest capitalized 2.52 M200 K — Non-Operating Income, excl. Interest Expenses -2.52 M4.11 M — Unusual income/expense 1.48 M4.14 M — Pretax income 32.98 M20.1 M — Equity in earnings —— — Taxes 81 K1.76 M — Non-controlling/minority interest 1.68 M2.06 M — After tax other income/expense —— — Net income before discontinued operations 31.38 M16.27 M — Discontinued operations —— — Net income 31.38 M16.27 M — Dilution adjustment 10.52 M0 — Preferred dividends 5.26 M0 — Diluted net income available to common stockholders 36.64 M16.27 M — Basic earnings per share (Basic EPS) -1.23-0.28 — Diluted earnings per share (Diluted EPS) -1.23-0.28 — Average basic shares outstanding 29.7 M58.41 M — Diluted shares outstanding 29.7 M58.41 M — EBITDA -49.17 M-52.21 M — EBIT -51.88 M-55.3 M — Cost of revenue 37.46 M33.5 M — Other cost of goods sold —— — Depreciation & amortization (cash flow) 2.7 M3.09 M —